{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for vitamin root_references_url in Reference URL (approximate match)
Status:
Other
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
Confiche Anti-Hair LossShampoo by H.L.C GROUP Co., ltd
(2022)
Source URL:
First approved in 2022
Source:
Confiche Anti-Hair LossShampoo by H.L.C GROUP Co., ltd
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
ProBionexxProbiotic Support by SKYA HEALTH, LLC
(2023)
Source URL:
First approved in 2022
Source:
Degong Ling by Shenzhen Deyintang Biotechnology Co., Ltd.
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
NCT01686698: Phase 4 Interventional Completed Cirrhosis
(2013)
Source URL:
First approved in 2022
Source:
Degong Ling by Shenzhen Deyintang Biotechnology Co., Ltd.
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
NCT04082598: Phase 4 Interventional Completed Tooth Extraction
(2016)
Source URL:
First approved in 2018
Source:
BOTANIC TWENTY RECHARGING TONER by RITZY NOBLE CO., LTD.
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
NCT01927094: Phase 4 Interventional Completed Acute Diarrhea
(2012)
Source URL:
First approved in 2015
Source:
21 CFR 352
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
NCT03117322: Phase 4 Interventional Completed Cerebral Palsy
(2017)
Source URL:
First approved in 2011
Source:
M020
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
BLA125397
(2011)
Source URL:
First approved in 2011
Source:
BLA125397
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Other
Class:
G1 SPECIFIED SUBSTANCE
Status:
Designated
Source:
FDA ORPHAN DRUG:814521
Source URL:
Class:
CONCEPT